Herbert Budka

Q: What Schools Are Affiliated With Herbert Budka

Herbert Budka is affiliated with the following schools: Medical University of Vienna, Kyoto University, University of Zurich, University of Vienna

Herbert Budka's AcademicInfluence.com Rankings

Herbert Budka

Philosophy

#5845

World Rank

#8761

Historical Rank

Logic

#3051

World Rank

#4152

Historical Rank

philosophy Degrees

Herbert Budka

Biology

#7866

World Rank

#10853

Historical Rank

Pathology

#101

World Rank

#208

Historical Rank

Neuroscience

#1051

World Rank

#1093

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Herbert Budka's Degrees

PhD Neuroscience University of Vienna
Doctorate Medicine Medical University of Vienna

Why Is Herbert Budka Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Herbert Budka's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects (1999) (1361)
Accumulation of abnormally phosphorylated τ precedes the formation of neurofibrillary tangles in Alzheimer's disease (1989) (787)
Scientific Opinion of the Panel on Biological Hazards (2007) (587)
Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt–Jakob disease (2000) (467)
Neuropathology of Human Immunodeficiency Virus Infection (1991) (438)
Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease? (1984) (432)
Patterns of oligodendroglia pathology in multiple sclerosis. (1994) (418)
Neuropathological Diagnostic Criteria for Creutzfeldt‐Jakob Disease (CJD) and Other Human Spongiform Encephalopathies (Prion Diseases) (1995) (407)
Genetic prion disease: the EUROCJD experience (2005) (403)
Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy (2015) (340)
HIV‐Associated Disease of the Nervous System: Review of Nomenclature and Proposal for Neuropathology‐Based Terminology (1991) (335)
Molecular classification of sporadic Creutzfeldt-Jakob disease. (2003) (334)
Mortality from Creutzfeldt–Jakob disease and related disorders in Europe, Australia, and Canada (2005) (329)
Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. (1992) (286)
Viral meningoencephalitis: a review of diagnostic methods and guidelines for management (2005) (264)
Recombinant prion protein induces a new transmissible prion disease in wild-type animals (2010) (263)
Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series (2013) (262)
Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. (2004) (261)
Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. (2006) (261)
No tissue damage by chronic deep brain stimulation in Parkinson's disease (2000) (258)
Scientific Opinion on the public health hazards to be covered by inspection of meat (swine) (2011) (252)
Endoplasmic Reticulum Stress Features Are Prominent in Alzheimer Disease but Not in Prion Diseases In Vivo (2006) (239)
Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease. (1998) (206)
Scientific Opinion on risk based control of biogenic amine formation in fermented foods 1 (2011) (197)
TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea (2009) (197)
Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesis. (2001) (195)
Viral encephalitis: a review of diagnostic methods and guidelines for management (2005) (193)
Peroxisomal alterations in Alzheimer’s disease (2011) (176)
Mutations of the prion protein gene phenotypic spectrum. (2002) (172)
Visualization of Central European tick-borne encephalitis infection in fatal human cases. (2005) (164)
Immunohistochemical Analysis of INI1 Protein in Malignant Pediatric CNS Tumors: Lack of INI1 in Atypical Teratoid/Rhabdoid Tumors and in a Fraction of Primitive Neuroectodermal Tumors without Rhabdoid Phenotype (2006) (159)
Brain pathology induced by infection with the human immunodeficiency virus (HIV) (1987) (157)
Globular glial tauopathies (GGT): consensus recommendations (2013) (155)
Brain Protein Preservation Largely Depends on the Postmortem Storage Temperature: Implications for Study of Proteins in Human Neurologic Diseases and Management of Brain Banks: A BrainNet Europe Study (2007) (154)
14‐3‐3 Proteins in Lewy Bodies in Parkinson Disease and Diffuse Lewy Body Disease Brains (2002) (153)
Mixed Brain Pathologies in Dementia: The BrainNet Europe Consortium Experience (2008) (148)
An Antigenic Profile of Lewy Bodies: Immunocytochemical Indication for Protein Phosphorylation and Ubiquitination (1989) (148)
The Original Gerstmann‐Sträussler‐Scheinker Family of Austria: Divergent Clinicopathological Phenotypes but Constant PrP Genotype (1995) (144)
Prion diseases: from protein to cell pathology. (2008) (143)
Natively unfolded tubulin polymerization promoting protein TPPP/p25 is a common marker of alpha-synucleinopathies (2004) (142)
Alterations in glia and axons in the brains of Binswanger's disease patients. (1997) (141)
Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease (1998) (141)
Evidence for Oxidative Stress in Experimental Prion Disease (2000) (137)
Vascular Patterns in Glioblastoma Influence Clinical Outcome and Associate with Variable Expression of Angiogenic Proteins: Evidence for Distinct Angiogenic Subtypes (2003) (135)
Neuropathological criteria of anti-IgLON5-related tauopathy (2016) (135)
Effects of Formalin Fixation, Paraffin Embedding, and Time of Storage on DNA Preservation in Brain Tissue: A BrainNet Europe Study (2007) (129)
Loss of neurons in the frontal cortex in AIDS brains (2004) (127)
An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology (2012) (125)
Neuropathology of prion diseases. (2003) (124)
Prion protein mutation in family first reported by Gerstmann, Sträussler, and Scheinker (1991) (123)
Multinucleated giant cells in brain: A hallmark of the acquired immune deficiency syndrome (AIDS) (2004) (123)
Expression of defective measles virus genes in brain tissues of patients with subacute sclerosing panencephalitis (1986) (121)
Amyloid-β pathology and cerebral amyloid angiopathy are frequent in iatrogenic Creutzfeldt-Jakob disease after dural grafting. (2016) (120)
Immunohistochemistry for the Prion Protein: Comparison of Different Monoclonal Antibodies in Human Prion Disease Subtypes (2002) (119)
D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid: a prescription for central nervous system amyloidosis? (2003) (115)
Inflammatory response in human tick-borne encephalitis: analysis of postmortem brain tissue (2006) (115)
Clonal expansion of hypermutated measles virus in a SSPE brain. (1993) (115)
Structure-based drug design identifies polythiophenes as antiprion compounds (2015) (110)
Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD 18G) (1996) (109)
Tissue Handling in Suspected Creutzfeldt‐Jakob Disease (CJD) and Other Human Spongiform Encephalopathies (Prion Diseases) (1995) (108)
SAMP8 mice as a neuropathological model of accelerated brain aging and dementia: Toshio Takeda's legacy and future directions (2017) (106)
Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium (2008) (106)
Advances in broad bandwidth light sources for ultrahigh resolution optical coherence tomography. (2004) (105)
White Matter Tauopathy With Globular Glial Inclusions: A Distinct Sporadic Frontotemporal Lobar Degeneration (2008) (105)
Monocyte subpopulations in human gliomas: expression of Fc and complement receptors and correlation with tumor proliferation (2004) (105)
Neuropathology of white matter disease in Leber's hereditary optic neuropathy. (2004) (103)
Scientific Opinion on a Quantitative Microbiological Risk Assessment of Salmonella in slaughter and breeder pigs (2010) (102)
Interlaboratory Comparison of Assessments of Alzheimer Disease-Related Lesions: A Study of the BrainNet Europe Consortium (2006) (102)
Mutations of the Prion Protein Gene (2002) (102)
Genesis of Mammalian Prions: From Non-infectious Amyloid Fibrils to a Transmissible Prion Disease (2011) (101)
Cyclooxygenase-2 is induced in microglia during chronic cerebral ischemia in humans (2000) (101)
Genetic Creutzfeldt-Jakob disease associated with the E200K mutation: characterization of a complex proteinopathy (2010) (99)
Intracellular processing of disease-associated α-synuclein in the human brain suggests prion-like cell-to-cell spread (2014) (97)
Blood-brain barrier dysfunction in Binswanger’s disease; an immunohistochemical study (1997) (96)
Scientific Opinion on an update on the present knowledge on the occurrence and control of foodborne viruses (2011) (93)
Imaging ex vivo healthy and pathological human brain tissue with ultra-high-resolution optical coherence tomography. (2005) (93)
Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion protein. (2006) (92)
Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics (2010) (91)
Familial meningocerebrovascular amyloidosis, Hungarian type, with mutant transthyretin (TTR Asp18Gly) (1996) (91)
A comparative study on the expression of cyclooxygenase and 5-lipoxygenase during cerebral ischemia in humans (2002) (90)
Presence, distribution and spread of productive varicella zoster virus infection in nervous tissues. (1992) (90)
Severe, Early and Selective Loss of a Subpopulation of GABAergic Inhibitory Neurons in Experimental Transmissible Spongiform Encephalopathies (1998) (88)
Distinct time pattern of complement activation and cytotoxic T cell response in Guillain-Barré syndrome. (2003) (88)
Inflammatory demyelinating polyradiculitis in a patient with multiple sclerosis. (1981) (88)
Neuronal Apoptosis in Fatal Familial Insomnia (1998) (87)
Ancestral origins and worldwide distribution of the PRNP 200K mutation causing familial Creutzfeldt-Jakob disease. (1999) (87)
Fatal familial insomnia: a new Austrian family. (1999) (86)
Subcellular localization of disease-associated prion protein in the human brain. (2005) (86)
Restricted expression of measles virus proteins in brains from cases of subacute sclerosing panencephalitis. (1986) (85)
Ki-67 Immunolabeling Index Is an Accurate Predictor of Outcome in Patients With Intracranial Ependymoma (2004) (84)
Inter-laboratory comparison of neuropathological assessments of β-amyloid protein: a study of the BrainNet Europe consortium (2008) (83)
Marked increase of neuronal prion protein immunoreactivity in Alzheimer's disease and human prion diseases (2001) (83)
Dura mater is a potential source of Aβ seeds (2016) (81)
Oxidative Damage to Nucleic Acids in Human Prion Disease (2002) (81)
Severe depletion of mitochondrial DNA in spinal muscular atrophy (2003) (81)
Scientific Opinion on Fish Oil for Human Consumption. Food Hygiene, including Rancidity (2010) (80)
Molecular Pathology of Human Prion Diseases (2009) (80)
Assessment of &agr;-Synuclein Pathology: A Study of the BrainNet Europe Consortium (2008) (79)
Distribution of Parvalbumin‐Immunoreactive Neurons in Brain Correlates with Hippocampal and Temporal Cortical Pathology in Creutzfeldt‐Jakob Disease (1997) (79)
Neuropathy Associated with Acrodermatitis Chronica Atrophicans Clinical and Morphological Features (1988) (78)
Involvement of the Endosomal-Lysosomal System Correlates With Regional Pathology in Creutzfeldt-Jakob Disease (2007) (78)
Pathology and Immunocytochemistry of a Kuru Brain (1997) (77)
Deposition of disease-associated prion protein involves the peripheral nervous system in experimental scrapie (1999) (76)
A peculiar constellation of tau pathology defines a subset of dementia in the elderly (2011) (76)
Risk assessment of biological hazards for consumer protection (2012) (75)
Complement activation in human prion disease (2004) (75)
Nucleus-specific alteration of raphe neurons in human neurodegenerative disorders (2003) (73)
Fatal Prion Disease in a Mouse Model of Genetic E200K Creutzfeldt-Jakob Disease (2011) (72)
Fibroblasts Can Express Glial Fibrillary Acidic Protein (GFAP) In Vivo (2001) (71)
Ganglionitis in paraneoplastic subacute sensory neuronopathy: A morphologic study (1997) (70)
Glial fibrillary acidic protein (GFAP) in oligodendroglial tumors: Gliofibrillary oligodendroglioma and transitional oligoastrocytoma as subtypes of oligodendroglioma (2004) (70)
Disease associated prion protein may deposit in the peripheral nervous system in human transmissible spongiform encephalopathies (1999) (70)
A New Mechanism for Transmissible Prion Diseases (2012) (69)
Neurofibrillary tangles in Alzheimer's disease and progressive supranuclear palsy: antigenic similarities and differences (1987) (69)
Ultrastructural study of florid plaques in variant Creutzfeldt–Jakob disease: a comparison with amyloid plaques in kuru, sporadic Creutzfeldt–Jakob disease and Gerstmann–Sträussler–Scheinker disease (2009) (67)
An immunocytochemical comparison of the glia-associated proteins glial fibrillary acidic protein (GFAP) and S-100 protein (S100P) in human brain tumors. (1986) (67)
Early Destruction of the Extracellular Matrix around Parvalbumin-Immunoreactive Interneurons in Creutzfeldt-Jakob Disease (1999) (67)
Fatal encephalitis caused by concomitant infection with tick-borne encephalitis virus and Borrelia burgdorferi. (1993) (66)
Pathogenesis of prion diseases (2005) (65)
Fibulin-5 mutations link inherited neuropathies, age-related macular degeneration and hyperelastic skin. (2011) (65)
Tubulin polymerization promoting protein (TPPP/p25) as a marker for oligodendroglial changes in multiple sclerosis (2010) (63)
Central nervous system pathology in patients with the Guillain-Barré syndrome. (1997) (63)
The brain-specific protein TPPP/p25 in pathological protein deposits of neurodegenerative diseases (2007) (62)
Proliferation and Dna fragmentation in meningioma subtypes (1997) (61)
Repermeation of partially embolized cerebral arteriovenous malformations: a clinical, radiologic, and histologic study. (1996) (61)
Redox metals and oxidative abnormalities in human prion diseases (2005) (61)
Comparative analysis of NeuN immunoreactivity in primary brain tumours: conclusions for rational use in diagnostic histopathology (2006) (61)
The need to unify neuropathological assessments of vascular alterations in the ageing brain Multicentre survey by the BrainNet Europe consortium (2012) (60)
Selective neuronal vulnerability in human prion diseases. Fatal familial insomnia differs from other types of prion diseases. (1999) (60)
Deposition patterns of disease-associated prion protein in captive mule deer brains with chronic wasting disease (2001) (60)
Assessment of the Public Health significance of meticillin resistant Staphylococcus aureus (MRSA) in animals and foods 1 (2009) (60)
Inter‐Laboratory Assessment of PrPSc Typing in Creutzfeldt–Jakob Disease: A Western Blot Study within the NeuroPrion Consortium (2009) (59)
Creutzfeldt–Jakob disease and inclusion body myositis: Abundant disease‐associated prion protein in muscle (2004) (59)
Neuroaxonal pathology in Creutzfeldt-Jakob disease (1999) (59)
Current concepts of neuropathological diagnostics in practice: neurodegenerative diseases. (2010) (58)
Medicinal and other products and human and animal transmissible spongiform encephalopathies: memorandum from a WHO meeting. (1997) (58)
Spastic paraplegia associated with addison's disease: Adult variant of adreno-leukodystrophy (2004) (58)
The Role of the NADPH Oxidase NOX2 in Prion Pathogenesis (2014) (58)
Human immunodeficiency virus (HIV)-induced disease of the central nervous system: pathology and implications for pathogenesis (2004) (57)
A novel phenotype in familial Creutzfeldt‐Jakob disease: Prion protein gene E200K mutation coupled with valine at codon 129 and type 2 protease‐resistant prion protein (1999) (57)
Request for updating the former SCVPH opinion on Listeria monocytogenes risk related to ready-to-eat foods and scientific advice on different levels of Listeria monocytogenes in ready-to-eat foods and the related risk for human (2007) (56)
Primitive neuroectodermal tumors including the medulloblastoma: glial differentiation signaled by immunoreactivity for GFAP is restricted to the pure desmoplastic medulloblastoma ("arachnoidal sarcoma of the cerebellum"). (1985) (56)
Intracranial lipomatous hamartomas (Intracranial “lipomas”) (1974) (55)
Excretion of Transmissible Spongiform Encephalopathy Infectivity in Urine (2008) (54)
Suprasellar meningioma with expression of glial fibrillary acidic protein: a peculiar variant (2004) (54)
Papillary glioneuronal tumor (2007) (54)
Pseudogliomatous growth pattern of anaplastic small cell carcinomas metastatic to the brain. (2001) (54)
Tau pathology in Creutzfeldt‐Jakob disease revisited (2016) (54)
Rosette-forming glioneuronal tumor of the fourth ventricle (2003) (53)
Foodborne antimicrobial resistance as a biological hazard (2008) (52)
Disease-associated prion protein in vessel walls. (2002) (52)
Accumulation of 14‐3‐3 proteins in glial cytoplasmic inclusions in multiple system atrophy (2002) (52)
Immunohistochemical Analysis of Platelet-derived Growth Factor Receptor-α, -β, c-kit, c-abl, and Arg Proteins in Glioblastoma: Possible Implications for Patient Selection for Imatinib Mesylate Therapy (2005) (52)
Fluorescent In Situ Hybridization on Isolated Tumor Cell Nuclei: A Sensitive Method for 1p and 19q Deletion Analysis in Paraffin-Embedded Oligodendroglial Tumor Specimens (2003) (51)
TAU AND UBIQUITIN IMMUNOREACTIVITY AT DIFFERENT STAGES OF FORMATION OF ALZHEIMER NEUROFIBRILLARY TANGLES (1989) (50)
Scientific Opinion on the maintenance of the list of QPS (qualified presumption of safety) biological agents intentionally added to food and feed (2010 update) (2010) (49)
Microbiological risk assessment in feedingstuffs for food-producing animals 1 Scientific Opinion of the Panel on Biological Hazards (2008) (49)
Accumulation of HtrA2/Omi in Neuronal and Glial Inclusions in Brains With &agr;-Synucleinopathies (2008) (49)
Nigral burden of α‐synuclein correlates with striatal dopamine deficit (2008) (49)
Immunohistochemical detection of cell growth fraction in formalin-fixed and paraffin-embedded murine tissue. (2001) (49)
Unilateral Creutzfeldt‐Jakob disease (1986) (48)
Fatal encephalitis in a patient with chronic graft-versus-host disease. (1990) (48)
The prion protein in human neurodegenerative disorders (2002) (47)
Progressive multifocal leukoencephalopathy in AIDS: initial and follow-up CT and MRI (1997) (46)
Distribution and cellular localization of adrenoleukodystrophy protein in human tissues: Implications for X-linked adrenoleukodystrophy (2007) (46)
In vivo expression of proinflammatory cytokines in HIV encephalitis: an analysis of 11 autopsy cases (2009) (46)
Progressive diffuse leukoencephalopathy in patients with acquired immune deficiency syndrome (AIDS) (2004) (46)
Kynurenic acid metabolism in the brain of HIV-1 infected patients (2000) (45)
Stabilization of a Prion Strain of Synthetic Origin Requires Multiple Serial Passages* (2012) (45)
Neuronal damage in the cerebral cortex of AIDS brains: a morphometric study (2004) (45)
Alzheimer-type neuropathology in a 28 year old patient with iatrogenic Creutzfeldt-Jakob disease after dural grafting (2005) (45)
Megadolichobasilar anomaly with thrombosis in a family with Fabry's disease and a novel mutation in the alpha-galactosidase A gene. (2005) (45)
Non-glial specificities of immunocytochemistry for the glial fibrillary acidic protein (GFAP) (1986) (45)
Intensity of human prion disease surveillance predicts observed disease incidence (2013) (44)
OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms (2007) (44)
JC virus granule cell neuronopathy and GCN–IRIS under natalizumab treatment (2013) (44)
Immunohistochemical Expression of Prion Protein (PrPC) in the Human Forebrain During Development (2006) (44)
How a neuropsychiatric brain bank should be run: a consensus paper of Brainnet Europe II (2006) (44)
Joint Scientific Opinion on any possible epidemiological or molecular association between TSEs in animals and humans (2011) (44)
Tickborne Encephalitis in Naturally Exposed Monkey (Macaca sylvanus) (2007) (43)
Value and limits of immunohistochemistry in differential diagnosis of clear cell primary brain tumors (2004) (43)
Neuropathology of the hippocampus in FTLD‐Tau with Pick bodies: a study of the BrainNet Europe Consortium (2013) (43)
Vascular cell components of the medullary arteries in Binswanger's disease brains: a morphometric and immunoelectron microscopic study. (2000) (43)
Creutzfeldt-Jakob disease in Austria. (1996) (42)
Prognostic relevance of intracytoplasmic cytokeratin pattern, hormone expression profile, and cell proliferation in pituitary adenomas of akromegalic patients. (2001) (42)
Papovavirus antigens in paraffin sections of PML brains. (1983) (42)
Prognostic relevance of p53 protein expression in glioblastoma. (2002) (42)
Neuroepithelial and ectomesenchymal differentiation in a primitive pineal tumor ("pineal anlage tumor"). (1989) (41)
Lipomatous differentiation in a medulloblastoma (2004) (40)
Scientific Opinion on Norovirus (NoV) in oysters: methods, limits and control options 1 (2012) (40)
Histopathological prognostic factors in medulloblastoma: high expression of survivin is related to unfavourable outcome. (2006) (39)
Partially resected und irradiated cerebellar astrocytoma of childhood: Malignant evolution after 28 years (2005) (39)
Glial fibrillary acidic protein and S-100 protein in human hepatic encephalopathy: Immunocytochemical demonstration of dissociation of two glia-associated proteins (2004) (39)
Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant (2016) (39)
Glioblastoma developing at the site of a cerebellar medulloblastoma treated 6 years earlier. Case report. (1987) (38)
Microglia is a component of the prion protein amyloid plaque in the Gerstmann-Sträussler-Scheinker syndrome (2004) (38)
Binswanger’s encephalopathy: serial sections and morphometry of the cerebral arteries (2000) (38)
Unclassifiable tauopathy associated with an A152T variation in MAPT exon 7. (2011) (37)
Survivin expression in intracranial ependymomas and its correlation with tumor cell proliferation and patient outcome. (2005) (37)
Vascularization and expression of hypoxia-related tissue factors in intracranial ependymoma and their impact on patient survival (2005) (37)
Vascular changes in white matter lesions of Alzheimer’s disease (1999) (37)
Scientific Opinion on a quantitative estimate of the public health impact of setting a new target for the reduction of Salmonella in laying hens (2010) (36)
Spontaneous mutations in the prion protein gene causing transmissible spongiform encephalopathy (2002) (36)
In situ analysis of cell kinetics in human brain tumors (1989) (36)
Human immunodeficiency virus (HIV) envelope and core proteins in CNS tissues of patients with the acquired immune deficiency syndrome (AIDS) (2004) (36)
Deposition of the prion protein (PrP) during the evolution of experimental Creutzfeldt-Jakob disease (1999) (35)
Creutzfeldt-Jakob Disease in Austria: An Autopsy-Controlled Study (2008) (35)
The Definition of HIV‐specific Neuropathology (1991) (35)
Upregulated Expression of 14-3-3 Proteins in Astrocytes From Human Cerebrovascular Ischemic Lesions (2006) (34)
Histopathology and immunohistochemistry of human transmissible spongiform encephalopathies (TSEs). (2000) (34)
Accumulation of very long chain fatty acids is common to 3 variants of adrenoleukodystrophy (ALD) “Classical” ALD, atypical ALD (female patient) and adrenomyeloneuropathy (1981) (33)
Accumulation of Hsc70 and Hsp70 in glial cytoplasmic inclusions in patients with multiple system atrophy (2007) (33)
Ultrastructural Characteristics (or Evaluation) of Creutzfeldt-Jakob Disease and Other Human Transmissible Spongiform Encephalopathies or Prion Diseases (2010) (33)
Morphological spectrum, distribution and clinical correlation of white matter lesions in AIDS brains (1992) (33)
The use and mode of action of bacteriophages in food production (2009) (32)
New lexicon and criteria for the diagnosis of Alzheimer's disease (2011) (32)
Overview of methods for source attribution for human illness from food-borne microbiological hazards (2008) (32)
Human transmissible spongiform encephalopathies in eleven countries: diagnostic pattern across time, 1993–2002 (2006) (32)
Alteration of the serotonergic nervous system in fatal familial insomnia (2000) (32)
High expression of DNA topoisomerase IIalpha and Ki-67 antigen is associated with prolonged survival in glioblastoma patients. (2002) (32)
Multisite Assessment of Aging-Related Tau Astrogliopathy (ARTAG) (2017) (32)
Absence of measles virus receptor (CD46) in lesions of subacute sclerosing panencephalitis brains (1997) (32)
Lipomatous medulloblastoma in adults: a new tumor type with possible favorable prognosis. (1994) (31)
Ultrastructural pathology of Gerstmann-Sträussler-Scheinker disease. (1995) (31)
Vascular changes in the cerebral cortex in HIV-1 infection: I. A morphometric investigation by light and electron microscopy. (1996) (31)
Neuroaxonal dystrophy combined with diffuse Lewy body disease in a young adult. (1993) (31)
Fibrous meningeal tumours with extensive non‐calcifying collagenous whorls and glial fibrillary acidic protein expression: the whorling‐sclerosing variant of meningioma (2002) (30)
Neuropathology : the diagnostic approach (1998) (30)
Prominent Stress Response of Purkinje Cells in Creutzfeldt–Jakob Disease (2001) (30)
Supratentorial lobar ependymomas: Reports on the grading and survival periods in 80 cases, including 46 recurrences (2005) (30)
Naturally Occurring Herpes Simplex Encephalitis in a Domestic Rabbit (Oryctolagus cuniculus) (1997) (30)
Asymmetry of neurodegenerative disease-related pathologies: a cautionary note (2012) (30)
Metallothionein overexpression in human brain tumours (1997) (30)
Reduced Expression of Excitatory Amino Acid Transporter 2 and Diffuse Microglial Activation in the Cerebral Cortex in AIDS Cases With or Without HIV Encephalitis (2009) (30)
Multifocal vacuolar leucoencephalopathy: a distinct HIV‐associated lesion of the brain ** (1990) (30)
T Cell–mediated ganglionitis associated with acute sensory neuronopathy (1996) (30)
Diagnostic and pathomorphological aspects of glioma multiplicity (2005) (29)
Distinctive cerebellar immunoreactivity for the prion protein in familial (E200K) Creutzfeldt-Jakob disease (2003) (29)
Herpes Simplex Virus (HSV) DNA in Microglial Nodular Brainstem Encephalitis (1989) (29)
Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study (2020) (29)
Human immunodeficiency virus in vacuolar myelopathy of the acquired immunodeficiency syndrome. (1988) (29)
TPPP/p25 in brain tumours: expression in non-neoplastic oligodendrocytes but not in oligodendroglioma cells (2007) (29)
Expression of myogenic regulatory factors and myo-endothelial remodeling in sporadic inclusion body myositis (2013) (28)
Autoradiography with [3H]PK11195 of spinal tract degeneration in amyotrophic lateral sclerosis (2001) (28)
No prognostic impact of survivin expression in glioblastoma (2005) (28)
Bilateral striopallidodentate calcification (Fahr's syndrome) and multiple system atrophy in a patient with longstanding hypoparathyroidism (2007) (28)
Cytomegalovirus (CMV) disease of the brain in AIDS and connatal infection: a comparative study by histology, immunocytochemistry and in situ DNA hybridization (2004) (28)
Prominent cortical atrophy with neuronal loss as correlate of human immunodeficiency virus encephalopathy (2004) (27)
Prominent corticosteroid disturbance in experimental prion disease (2006) (27)
Contribution of histiocytic cells to sarcomatous development of the gliosarcoma (2004) (26)
14-3-3 proteins in Lewy body-like hyaline inclusions in patients with sporadic amyotrophic lateral sclerosis (2004) (26)
A Genome Wide Association Study Links Glutamate Receptor Pathway to Sporadic Creutzfeldt-Jakob Disease Risk (2015) (26)
Pleomorphic xanthoastrocytoma with anaplastic features presenting without GFAP immunoreactivity: Implications for differential diagnosis (2005) (26)
Topographical and cytopathological lesion analysis of the white matter in Binswanger’s disease brains (2004) (25)
Argyrophilic nucleolar organizer region proteins (Ag-NORs) in human brain tumors: relations with grade of malignany and proliferation indices (2004) (24)
Increased incidence of sporadic Creutzfeldt‐Jakob disease on the island of Crete associated with a high rate of PRNP 129‐methionine homozygosity in the local population (2001) (24)
Vacuolar myelopathy with multinucleated giant cells in the acquired immune deficiency syndrome (AIDS) (2004) (24)
Neuropathology of myelitis, myelopathy, and spinal infections in AIDS. (1997) (23)
Danon disease: Case report and detection of new mutation (2009) (23)
Occurrence of IgA subclasses (IgA1 and IgA2) in the human nervous system. Correlation with disease. (1985) (23)
Endothelial and Myogenic Differentiation of Hematopoietic Progenitor Cells in Inflammatory Myopathies (2008) (23)
The developing brain and its disorders (1986) (23)
An autosomal dominant early adult‐onset distal muscular dystrophy (2000) (23)
Contribution of neuropathology to the understanding of human prion disease. (2004) (23)
Early infantile form of Krabbe disease with optic hypertrophy: serial MR examinations and autopsy correlation. (1994) (22)
A case of variably protease-sensitive prionopathy treated with doxycyclin (2015) (22)
The ubiquitin–proteasome system in Creutzfeldt–Jakob and Alzheimer disease: Intracellular redistribution of components correlates with neuronal vulnerability (2005) (22)
Progressive multifocal leukoencephalopathy (PML) in AIDS and in the pre-AIDS era. A neuropathological comparison using immunocytochemistry and in situ DNA hybridization for virus detection. (1990) (22)
Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens (2004) (22)
Neocortical changes in Parkinson's disease, revisited. (1994) (22)
Cystatin F is a biomarker of prion pathogenesis in mice (2017) (21)
Distribution of intraneuronal immunoreactivity for the prion protein in human prion diseases (2002) (21)
Hyaline inclusions (pseudopsammoma bodies) in meningiomas: Immunocytochemical demonstration of epithel-like secretion of secretory component and immunoglobulins A and M (2004) (21)
Phenotypic and functional complexity of brain-infiltrating T cells in Rasmussen encephalitis (2017) (21)
Increased 14-3-3 immunoreactivity in glial elements in patients with multiple sclerosis (2004) (21)
Proliferative Activity as Measured by MIB-1 Labeling Index and Long-term Outcome of Cerebellar Juvenile Pilocytic Astrocytomas (2002) (21)
Prion disease with a 144 base pair insertion: unusual cerebellar prion protein immunoreactivity (2005) (20)
Tubulovesicular structures in Creutzfeldt-Jakob disease (2004) (20)
Antibody 9D5 recognizes oligomeric pyroglutamate amyloid-β in a fraction of amyloid-β deposits in Alzheimer's disease without cross-reactivity with other protein aggregates. (2012) (20)
Cerebellar dysfunction in a family harboring the PSEN1 mutation co-segregating with a Cathepsin D variant p.A58V (2013) (20)
Subacute measles virus encephalitis (1996) (20)
Acute motor and sensory axonal neuropathy in Burkitt‐like lymphoma (2006) (20)
Fulminant central nervous system demyelination associated with interferon-α therapy and hepatitis C virus infection (2007) (19)
Malnutrition-induced hypokalemic myopathy in chronic alcoholism. (1998) (19)
Neocortical neurones may be targeted by immune attack in anti‐Yo paraneoplastic syndrome (2008) (19)
Greenfield's Neuropathology - Two Volume Set (2018) (19)
Intraneuronal Immunoreactivity for the Prion Protein Distinguishes a Subset of E200K Genetic From Sporadic Creutzfeldt-Jakob Disease (2012) (19)
Synucleinopathy with features of both multiple system atrophy and dementia with Lewy bodies (2007) (19)
Human immunodeficiency virus in glial cells? (1988) (19)
Development of HIV encephalitis in AIDS and TNF-α regulatory elements (1998) (19)
Cerebral manifestations of Whipple's disease. (1979) (18)
Determination of proliferative activities in human brain tumor specimens: a comparison of three methods (1991) (18)
Disproportionate subarachnoid space hydrocephalus—outcome and perivascular space (2014) (18)
Nail-Patella Syndrome Associated with Respiratory Chain Disorder (2001) (18)
Diagnostic value of stereotactic biopsy of cerebral lesions in patients with AIDS (2005) (18)
Neuroaxonal dystrophy in experimental Creutzfeldt-Jakob disease: electron microscopical and immunohistochemical demonstration of neurofilament accumulations within affected neurites. (1995) (17)
Production of glial fibrillary acidic protein (GFAP) by neoplastic cells: Adaptation to the microenvironment (2004) (17)
SSPE-like inclusion body disorder in treated childhood leukemia. (1975) (17)
The prion protein in human neuromuscular diseases (2004) (17)
Langerhans cell histiocytosis of the hypothalamus: diagnostic value of immunohistochemistry. (1996) (17)
Rationale for diagnosing human prion disease (2004) (17)
Brain tissue immunoglobulins in adrenoleukodystrophy: A comparison with multiple sclerosis and systemic lupus erythematosus (2004) (17)
Fatal Neurological Disease in Scrapie-Infected Mice Induced for Experimental Autoimmune Encephalomyelitis (2007) (17)
Benign mixed glial-mesenchymal tumour (“glio-fibroma”) of the spinal cord (2005) (16)
Serotonergic nuclei of the raphe are not affected in human ageing (2001) (16)
Distribution of apoptosis-related proteins in sporadic Creutzfeldt–Jakob disease (2010) (16)
The end of the BSE saga: do we still need surveillance for human prion diseases? (2015) (16)
Shared antigenic determinants between human hemopoietic cells and nervous tissues and tumors (2004) (16)
Intrathecal anti-αB-crystallin IgG antibody responses: Potential inflammatory markers in Guillain-Barré syndrome (2008) (15)
DNA topoisomerase IIα expression in optic pathway gliomas of childhood (2002) (15)
Intermittent meningitic reaction with severe basophilia and eosinophilia in CNS leukaemia A special type of hypersensitivity (1976) (15)
Tubulovesicular structures are a consistent (and unexplained) finding in the brains of humans with prion diseases. (2008) (15)
Inherited prion disease with A117V mutation of the prion protein gene: a novel Hungarian family (2001) (15)
Scientific Opinion on BSE/TSE infectivity in small ruminant tissues (2010) (15)
Diffuse Lewy body disease as substrate of primary lateral sclerosis (2004) (15)
Primary leptomeningeal sarcomatosis (1975) (14)
Uncommon types of polyglucosan bodies in the human brain: distribution and relation to disease (2004) (14)
The significance of nucleolar organizer region (AgNOR) score in predicting meningioma recurrence (1994) (14)
Immunohistological Demonstration of Serum Proteins and Structural and Viral Antigens in Paraffin Sections of Nervous Tissues (1983) (14)
[Creutzfeldt-Jakob disease in a dura transplant recipient: first observation in Austria]. (1998) (14)
The neuropathology of HIV-associated brain disease. (2005) (14)
Rapidly progressive dementia with thalamic degeneration and peculiar cortical prion protein immunoreactivity, but absence of proteinase K resistant PrP: a new disease entity? (2013) (13)
The role of parvalbumin and calbindin D28k in experimental scrapie (2008) (13)
Enhanced expression of 14-3-3 proteins in reactive astrocytes in Creutzfeldt-Jakob disease brains (2004) (13)
Peroxisomal localization of the proopiomelanocortin-derived peptides beta-lipotropin and beta-endorphin. (2010) (13)
DEC1 expression in 1p-aberrant oligodendroglial neoplasms. (2005) (13)
Antigenic profile of human recombinant PrP: generation and characterization of a versatile polyclonal antiserum (2004) (12)
Cathepsin D (C224T) Polymorphism in Sporadic and Genetic Creutzfeldt-Jakob Disease (2010) (12)
MRI features of Binswanger’s disease predict prognosis and associated pathology (2014) (12)
Progressive multifocal leukoencephalopathy (PML) in AIDS and in the pre-AIDS era (2004) (12)
K27/G34 versus K28/G35 in histone H3-mutant gliomas: A note of caution (2018) (12)
Cerebral pathology in AIDS: a new nomenclature and pathogenetic concepts. (1992) (12)
Prion protein (PrP) deposits in the tectum of experimental Gerstmann-Sträussler-Scheinker disease following intraocular inoculation. (2012) (12)
A quantitative microbiological risk assessment on Salmonella in meat 1 : Source attribution for human salmonellosis from meat 2 (2008) (12)
Aging, the brain and human prion disease (2002) (12)
BSE and variant Creutzfeldt-Jakob disease: never say never (2002) (11)
Prions and transfusion medicine. (2000) (11)
Development of HIV encephalitis in AIDS and TNF-alpha regulatory elements. (1998) (11)
BSE and TSEs: Past, present and future (2008) (11)
Immunohistochemical detection of class III β‐tubulin in primary brain tumours: variable expression in most tumour types limits utility as a differential diagnostic marker (2007) (11)
Iatrogenic Creutzfeldt–Jakob disease 22 years after human growth hormone therapy: clinical and radiological features (2008) (11)
Quantitative estimation of the impact of setting a new target for the reduction of Salmonella in breeding hens of Gallus gallus 1 (2009) (10)
[A case of progressive multifocal leucoencephalopathy during chronic lymphocytic leukaemia]. (1993) (10)
Testing for prion protein does not confirm previously reported conjugal CJD (1996) (10)
Tubulovesicular structures in Gerstmann-Sträussler-Scheinker disease (2004) (10)
[Infarction of the spinal cord in the posterior spinal arterial supply area as a result of intervertebral disc embolism (author's transl)]. (1979) (10)
Editorial: The European Response to BSE: A Success Story (2011) (10)
Increased neuronal Rab5 immunoreactive endosomes do not colocalize with TDP-43 in motor neuron disease (2010) (9)
Foodborne viruses and prions and their significance for public health (2013) (9)
Brain Pathology in the Collagen Vascular Diseases (1981) (9)
The human prion diseases: from neuropathology to pathobiology and molecular genetics (1997) (9)
Non‐HTLV‐I associated pleomorphic T‐cell lymphoma of the brain mimicking post‐vaccinal acute inflammatory demyelination (1997) (9)
Proliferative Activity as Measured by MIB-1 Labeling Index and Long-term Outcome of Visual Pathway Astrocytomas in Children (1999) (9)
The cerebral cortex in fetal Down syndrome. (2003) (9)
Comparison of in situ DNA hybridization (ISH) and immunocytochemistry for diagnosis of herpes simplex virus (HSV) encephalitis in tissue (2004) (9)
The human prion diseases: from neuropathology to pathobiology and molecular genetics. Final report of an EU concerted action. (1997) (9)
Opinion of the Scientific Panel on Biological Hazards on a request from the European Parliament on the assessment of the health risks of feeding of ruminants with fishmeal in relation to the risk of TSE (2007) (9)
[Consensus report: tissue handling in suspected Creutzfeldt-Jakob disease and other spongiform encephalopathies (prion diseases) in the human. European Union Biomed-1 Concerted Action]. (1996) (9)
Rabies and Herpes simplex virus encephalitis (2004) (8)
Primary glioblastoma of the cerebellum (1974) (8)
Myofibrillar (desmin-related) myopathy: clinico-pathological spectrum in 3 cases and review of the literature. (2002) (8)
HIV-Related Dementia: Pathology and Possible Pathogenesis (1993) (8)
Genetic Creutzfeldt–Jakob disease mimicking variant Creutzfeldt–Jakob disease (2009) (8)
Reduction in Serum Aquaporin-4 Antibody Titers During Development of a Tumor-Like Brain Lesion in a Patient With Neuromyelitis Optica: A Serum Antibody–Consuming Effect? (2015) (8)
Autopsy at 2 months after death: brain is satisfactorily preserved for neuropathology. (2007) (8)
Novel crystalloid oligodendrogliopathy in hereditary spastic paraplegia (2012) (8)
The Spectrum of Tau Pathology in Human Prion Disease (2013) (8)
DNA topoisomerase IIalpha expression in optic pathway gliomas of childhood. (2002) (8)
Scientific Opinion on a second update on the risk for human and animal health related to the revision of the BSE monitoring regime in some Member States (2010) (8)
Neuropathology of AIDS dementia. A review after 205 post mortem examinations. (1990) (8)
Protein-Based Neuropathology and Molecular Classification of Human Neurodegenerative Diseases (2009) (8)
Dysembryoplastic Neuroectodermal Tumor: An Ultrastructural Study of Six Cases (2001) (7)
Monitoring and identification of human enteropathogenic Yersinia spp . 1 Scientific Opinion of the Panel on Biological Hazards ( Question No EFSA-Q-2007-037 ) Adopted by the BIOHAZ Panel on 6 December 2007 (2007) (7)
[Stereotactic brain biopsy in AIDS patients: a necessary patient-oriented and cost-effective diagnostic measure?]. (1998) (7)
Devic's neuromyelitis optica and Schilder's myelinoclastic diffuse sclerosis (1992) (7)
Assessment of the possible effect of the four antimicrobial treatment substances on the emergence of antimicrobial resistance 1 (2008) (7)
Cytopathological alterations and therapeutic approaches in Binswanger's disease (1999) (7)
Secretagogin expression in tumours of the human brain and its coverings (2007) (7)
Food safety aspects of dairy cow housing and husbandry systems (2009) (7)
Pathogenesis of Human Immunodeficiency Virus (HIV)‐Associated Brain Lesions A Neuropathologic Evaluation (1988) (6)
Subacute diencephalic angioencephalopathy: an entity similar to angiodysgenetic necrotizing encephalopathy and Foix-Alajouanine disease (1992) (6)
Autoradiography with [ 3 H ] PK 11195 of spinal tract degeneration in amyotrophic lateral sclerosis (6)
Pathology of Midline Brain Tumors (1985) (6)
Scientific Opinion on Risk of transmission of TSEs via semen and embryo transfer in small ruminants ( sheep and goats ) 1 EFSA Panel on Biological Hazards (2010) (6)
Echigo-1: a panencephalopathic strain of Creutzfeldt-Jakob disease. II. Ultrastructural studies in hamsters. (2004) (6)
[Stereotaxic biopsy of cerebral lesions. Results based on a series of 250 cases]. (1992) (6)
External granular cell layer bobbling: a distinct histomorphological feature of the developing human cerebellum. (2013) (6)
[Epidemiology of transmissible spongiform encephalopathies (prion diseases) in Austria]. (1998) (6)
The human prion diseases--from neuropathology to pathobiology and molecular genetics: an update, Vienna, Austria, 6-7 December 1996. (1997) (6)
Iatrogenic and sporadic Creutzfeldt-Jakob disease in 2 sisters without mutation in the prion protein gene (2015) (6)
Measles virus antigen in panencephalitis (2004) (6)
Fatal familial insomnia around the world. Introduction. (1998) (6)
Morphometry of synaptophysin immunoreactive ganglion cells in Auerbach plexus in patients with colorectal cancer. Is this a new prognostic factor (2004) (5)
The majority of dystrophic neuritesin Alzheimer disease (AD) and all neurites in Gerstmenn-Straussler-Scheinker disease (GSS) do not contain paired helical filaments and do not express MAP tau (tau) (1995) (5)
Opinion of the Scientific Panel on Biological Hazards on the safety vis-à-vis biological risk of the mesophilic process of biogas and compost treatment of Animal By-Products (ABPs) 1 (2007) (5)
HIV‐lnduced CNS Lesions (1991) (5)
A new Austrian family with fatal familial insomnia: Brain pathology without detectable PrPres (1997) (5)
Clinical, radiological and histological presentations of dysembryoplastic neuroepithelial tumors (DNT). Report of two cases. (1996) (5)
Primary neuroendocrine (merkel cell) carcinoma of the anterior skull base. (1997) (5)
125th anniversary of the Institute of Neurology (Obersteiner Institute) in Vienna. "Germ Cell" of interdisciplinary neuroscience. (2008) (5)
[Iatrogenic Creutzfeldt-Jakob disease]. (1998) (5)
Immunohistological studies in viral encephalitis. (1981) (5)
Development of stroma in malignant lymphomas of the brain compared with epidural lymphomas (1986) (5)
Encephalitogenic peptide (EP) in human cerebrovascular white matter lesions (1997) (5)
Expression of DNA topoisomerase IIalpha in oligodendroglioma. (2002) (5)
[Primary diffuse melanoblastosis of the meninges and neuro-cutaneous melanosis (author's transl)]. (1973) (5)
[Slow-virus "encephalitis" following measles in a child with cytostatically-treated leukaemia (author's transl)]. (1975) (5)
Expression of hypoxia‐inducible factor–1α in oligodendrogliomas (5)
Distinctive cerebral neuropathology in an adult case of SANDO syndrome (2017) (4)
Imported human rabies in Switzerland, 2012: a diagnostic conundrum. (2013) (4)
Phenotypic variation in Creutzfeldt‐Jakob disease, May 31 and June 1, 1996, Vienna, Austria (1996) (4)
[Cerebrospinal fluid diagnosis of Creutzfeldt-Jakob disease]. (1998) (4)
Malignant predominantly minigemistocytic glioma in two infants: a distinctive glioma variant? (2007) (4)
[Immunologic hormone detection in hypophyseal adenomas: correlation of serum hormone findings with immunocytochemical hormone levels in tumor tissue]. (1988) (4)
Pathology of midline brain tumors. Immunocytochemical tumor markers and classificatory aspects. (1985) (4)
Neurochemical investigations of aged human brain cortex. (1982) (4)
Food Safety considerations of animal welfare aspects of husbandry systems (2008) (4)
Immunohistochemical study of apolipoprotein E in human cerebrovascular white matter lesions (1995) (4)
Statement on a request from the European Commission for the assessment of the scientific elements supporting the prohibition for the placing on the market of GM potato EH92-527-1 for cultivation purposes in Austria (2012) (4)
The autophagic marker p62 highlights Alzheimer type II astrocytes in metabolic/hepatic encephalopathy (2020) (3)
Imaging brain morphology with ultrahigh-resolution optical coherence tomography (2003) (3)
Scientific Opinion on a review of the BSE-related risk in bovine intestines (2011) (3)
QUANTITATIVE RISK ASSESSMENT ON THE RESIDUAL BSE RISK IN SHEEP MEAT AND MEAT PRODUCTS (2007) (3)
Immunostaining for ubiquitin: efficient pretreatment (2003) (3)
[Stereotaxic biopsy of intracranial processes: validity of histologic diagnosis]. (1989) (3)
Presence of D110 antigen expressing immunocompetent cells in glioblastoma associates with prolonged survival (2004) (3)
CNS DISTRIBUTION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) ANTIGENS IN AIDS: 249 (1989) (3)
[Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease]. (1998) (3)
[Multifocal motor neuropathy with conduction block--a clinico-neuropathologic case report]. (1996) (3)
Opinion of the Scientific Panel on Biological Hazards on certain aspects related to the risk of Transmissible Spongiform Encephalopathies (TSEs) in ovine and caprine animals 1 (2007) (3)
Scientific Opinion on Hatchery Waste as animal by-products (2011) (3)
Megalencephaly and chromosomal anomaly (1978) (3)
[Neuropathology of renal transplantation (author's transl)]. (1976) (3)
Targeting of prion-infected lymphoid cells to the central nervous system accelerates prion infection (2012) (3)
An antibody with high reactivity for disease-associated a-synuclein reveals extensive brain pathology Gabor G. KovacsUta WagnerBenoit DumontMaria PikkarainenAwad A. Osman • Nathalie StreichenbergerIrene LeisserJeremy VerchereThierry BaronIrina Alafuzoff • (2012) (3)
Scientific Opinion on the Neste Oil Application for a new alternative method of disposal or use of Animal By-Products (2010) (3)
Prion diseases: an introduction (2013) (2)
Correction: Fatal Prion Disease in a Mouse Model of Genetic E200K Creutzfeldt-Jakob Disease (2017) (2)
Molecular genetics of Creutzfeldt-Jakob disease and Gerstmann- Sträussler- Scheinker disease (2015) (2)
Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease. (2001) (2)
HIV and brain pathology: where do we go from here? (1996) (2)
The Austrian FFI Cases (1998) (2)
Glial bundles in spinal nerve roots (1984) (2)
Tubulovesicular structures in human and experimental Creutzfeldt-Jakob disease (1991) (2)
Echigo-1: a panencephalopathic strain of creutzfeldt-jakob disease. I. neuropathological and immunohistochemical studies. (2004) (2)
Creutzfeldt-Jakob disease with unusually extensive neuropathology in a child treated with native human growth hormone (2012) (2)
[Hypernephroma and associated AL-amyloidosis with polyneuropathy in monoclonal gammopathy]. (1993) (2)
Genome-wide association study identifies risk variants for sporadic Creutzfeldt-Jakob disease in STX6 and GAL3ST1 (2020) (2)
Sporadic Creutzfeldt-Jakob disease VM1: phenotypic and molecular characterization of a novel subtype of human prion disease (2022) (2)
Opinion of the Scientific Panel on Biological Hazards on the human and animal exposure risk related to Transmissible Spongiform Encephalopathies (TSEs) from milk and milk products derived from small (2008) (2)
Food safety aspects of different pig housing and husbandry systems 1 Scientific Opinion of the Panel on Biological Hazards (2007) (2)
TSE risk assessment from carcasses of ovine and caprine animals below 6 months of age from TSE infected flocks intended for human consumption 1 Scientific Opinion of the Panel on Biological Hazards (2008) (2)
Very Long Chain Fatty Acids and Phytanic Acid in Genetic Peroxisomal Diseases (1988) (1)
Feasibility of ultrahigh resolution optical coherence tomography for imaging brain tissue morphology and function (2004) (1)
Co‐incidental C9orf72 expansion mutation‐related frontotemporal lobar degeneration pathology and sporadic Creutzfeldt−Jakob disease (2020) (1)
Advocacy for Neuropathology (2011) (1)
Hereditary cerebellar atrophy (Holmes type) with optic atrophy (1979) (1)
THE SIGNIFICANCE OF NUCLEOLAR ORGANIZER REGION (AGNOR) SCORE IN PREDICTINGMENINGIOMA RECURRENCE. AUTHOR REPLY (1995) (1)
[Transmissible spongiform encephalopathies--illnesses in the human]. (1998) (1)
Concern about Mad Cow Disease: End of the beginning, or beginning of the end? (2004) (1)
Central Nervous System Immunoglobulins (Ig) in Adrenoleukodystrophy (ALD) (1983) (1)
Sensory Neuropathies (1995) (1)
Sensory Neuropathies (1995) (1)
Scientific Opinion on a summary of scientific studies undertaken by the UK Food Standards Agency to support a proposed production method for smoked “skin-on” sheep meat (2011) (1)
Rapidly progressive dementia with thalamic degeneration and peculiar cortical prion protein immunoreactivity, but absence of proteinase K resistant PrP: a new disease entity? (2013) (1)
In vitro BUdR labeling of brain-tumor specimens. (1989) (1)
Fourth meeting of the European Neurological Society 25–29 June 1994 Barcelona, Spain (1994) (1)
PAPOVA VIRAL ANTIGENS IN PML BRAINS: 76 (1982) (1)
The prevalence of Creutzfeldt-Jakob disease. (1996) (1)
Cross-reactivity between human hemopoietic cells and brain tumors as defined by monoclonal antibodies (2005) (1)
[Spinal pathology in spinal muscular atrophy in comparison with amyotrophic lateral sclerosis]. (1996) (1)
P4-152 Enlarged multivesicular bodies in Gerstmann-Straussler-Scheinker disease suggest the involvement of microautophagy in prion diseases, pathogenesis (2006) (1)
Foodborne viruses: an introduction (2013) (1)
Novel TARDBP mutation associated with frontotemporal dementia and movement disorder but not motor neuron disease (2009) (1)
Verbal perseveration as the initial symptom in a case of Creutzfeldt‐Jakob disease (2007) (1)
Transmissible Spongiform Encephalopathy (TSE) risk assessment of the use of bovine spray dried red cells in feeds for fish, in consideration of a report produced by the European Animal Protein Association 1 (2007) (1)
Distinctive cerebral neuropathology in an adult case of sensory ataxic neuropathy with dysarthria and ophthalmoplegia (SANDO) syndrome (2018) (1)
East-West Danube symposium on human and zoonotic spongiform encephalopathies, in Bratislava, Czechoslovakia, May 22-23, 1991. (1991) (1)
Ten years of EC-funded concerted actions on the neuropathology of prion disease: report on the final scientific meeting (31 October-2 November 2003, Baden near Vienna, Austria). (2004) (1)
23 MONOCLONAL ANTIBODIES RAISED AGAINST HEMOPOIETIC CELLS: CROSSREACTIVITY WITH NERVOUS TISSUES AND TUMORS (1984) (1)
NEUROPATHOLOGICALLY CONFIRMED SPORADIC CREUTZFELDT-JAKOB DISEASE: INCIDENCE IN AUSTRIA, AND PATTERNS AND DISTRIBUTION OF PRP DEPOSITS IN BRAIN (1996) (1)
ISN Information Days at the University of Witwatersrand Medical School, Johannesburg (South Africa) on September 23rd–24th, 2013 (2014) (1)
Letter to the case (1989) (1)
[CSF cytology in primary diffuse meningeal melanoblastosis (author's transl)]. (1973) (1)
Symposia on Neurodegenerative Disorders: Common Molecular Mechanisms, Ocho Rios, Jamaica, February 1993 * and April 1994 (1994) (1)
Biological Perspectives Prion Diseases: From Protein to Cell Pathology (2008) (1)
Pathogenesis of HIV-associated brain lesions: A neuropathological evaluation (1987) (1)
Author ' s personal copy Distribution and cellular localization of adrenoleukodystrophy protein in human tissues : Implications for X-linked adrenoleukodystrophy (2007) (1)
Sporadic Creutzfeldt-Jakob disease VM1: phenotypic and molecular characterization of a novel subtype of human prion disease (2022) (1)
Reply (2001) (0)
P069: MRI features of Binswanger's disease predict poor prognosis and associated brain pathology: A community-based birth cohort investigation (The Vienna Trans-Danube Aging Study) (2014) (0)
XIXth International Winter Meeting of the Swiss Society of Neuropathology \ldDegeneration and Regeneration of the Nervous System\rd St. Moritz, Switzerland, March 21\2-24, 2002 (2002) (0)
BiP can function as a molecular shepherd that alleviates oligomer toxicity and amass amyloid (2008) (0)
Biological Safety of a Process for the Hydrolysis on-Farm of Dead Rabbits 1 Scientific Opinion of the Panel on Biological Hazards (2008) (0)
The phenotype associated with the novel A152T mutation in MAPT exon 7 (2009) (0)
CASE Primary Neuroendocrine (Merkel Cell) Carcinoma of the Anterior Skull Base (2006) (0)
P2-208: Tubulovesicular structures are a consistent finding in the brains of humans and animals with prion diseases (2008) (0)
Risk management for foodborne prions (2013) (0)
Updated risk for human and animal health related to the revision of the BSE monitoring regime in some Member States 1 Scientific Opinion of the Panel on Biological Hazards (2008) (0)
HADDOCK calculated model of LIN5001 bound to the HET-s amyloid (2017) (0)
Multiple intracranial cavernomas with focal amyloid deposition – diagnostic pitfalls (2011) (0)
[The frequency of central nervous system manifestations in adult acute leukemia]. (1976) (0)
Cerebral manifestations of whipples disease (1979) (0)
Complex tauopathies vs. tangle predominant dementia (2011) (0)
Human and animal exposure risk related to Transmissible Spongiform Encephalopathies (TSEs) from milk and milk products derived from small ruminants (2008) (0)
Community-based comprehensive neuropathological survey in the elderly reveals wider range of neurodegenerative pathologies than assumed (2012) (0)
Flaviviruses 1 (2020) (0)
Introduction (1998) (0)
Expression ofDefective Measles VirusGenesinBrainTissues of Patients withSubacute Sclerosing Panencephalitis (1986) (0)
IMMUNOCYTOCHEMICAL DETECTION OF DISEASE-ASSOCIATED PRION PROTEIN IN THE PERIPHERAL NERVOUS SYSTEM OF PRION DISEASE (1999) (0)
NIMODIPINE DOES NOT REDUCE BRAIN DAMAGE AFTER VENTRICULAR FIBRILLATION IN AN ACUTE PIG MODEL (1988) (0)
First International Editorial Board Meeting for Neuropathology, September 1997, Perth, Australia (1998) (0)
Further consideration of age-related parameters on the Risk for Human and Animal Health related to the revision of the BSE Monitoring regime in some (2008) (0)
Advocacy for Neuropathology in practice: ISN Information Days (2012) (0)
Viral Meningo‐Encephalitis (2010) (0)
cells in vivo and evidence for its clinical significance. (1988) (0)
Status of ICN 2010 (2010) (0)
New monoclonal antibody 5G4 suitable for specific detection of disease-associated alpha-synuclein in the human brain (2012) (0)
Contents Vol. 30, 2008 (2008) (0)
Status of ICN 2010 (2010) (0)
Reply (1996) (0)
Pathology of the peripheral nervous system in unselected AIDS autopsies (1995) (0)
Project to study alternatives to carcass destruction systems using the bunker system 1 Scientific Opinion of the Panel on Biological Hazards ( Question No EFSA-Q-2008-713 ) Adopted on 21 January 2009 (2009) (0)
Six-year survival of progressive multifocal leukoencephalopathy associated with follicular lymphoma (2013) (0)
Fatal cerebral haemorrhage in a hypertensive seven-year-old boy (2016) (0)
DEAR READER (2007) (0)
Response to Commentary “POLG1/ANT1-Related SANDO is a Multisystem Mitochondrial Disorder” (2018) (0)
Meeting Report (1997) (0)
Endorphin Peroxisomal Localization of the Proopiomelanocortin-Derived Peptides (2010) (0)
Prion diseases--light at the end of the tunnel? (1999) (0)
BOOK REVIEW Greenfield’s Neuropathology, Ninth Edition: 2-Volume Set (2015) (0)
Post‐Salzburg Blues vs. Rise to New Horizons? (2011) (0)
Trilobar holoprosencephaly (“triprosencephaly”): a unique type of cerebral malformation (2004) (0)
PPo5-1: Deposition of Multiple Proteins in E200K Genetic Creutzfeldt-Jakob Disease (2010) (0)
Central Pathogenesis of Prion Diseases (2005) (0)
[Sporadic juvenile amyotrophic lateral sclerosis with neuronal basophil inclusion bodies--a nosologic entity?]. (1996) (0)
Molecular classi ® cation of sporadic Creutzfeldt ± Jakob disease (0)
469 Combination of Alzheimer's disease with Creutzfeldt-Jakob disease: A neuropathological study (1996) (0)
Erratum: Familial meningocerebrovascular amyloidosis, Hungarian type, with mutant transthyretin (TTR Asp18G1) (Neurology (Dec. 1996) (1562-1567)) (1997) (0)
Author reply (2002) (0)
[Immunomorphological investigations of viral antigens in various encephalitides]. (1981) (0)
Malignant Fetal Brain Tumor - Diagnosis, Management, Prognosis. Case Report and Literature Review (2014) (0)
P3-198 A case of early onset Alzheimer’s disease with cotton wool plaques but without spastic paraparesis (2006) (0)
Prions and the BSE connection: A boost for neurpathology (2002) (0)
Opinion on quantitative histological studies and the re-assessment of the BSE related risk of bovine intestines after processing into natural sausage casings 1 (2007) (0)
Welcome to ICN 2010 (2010) (0)
P276: MRI features of iNPH reveal motor and cognitive impairments and perivascular space derangement: a community-based birth cohort investigation (The Vienna Trans-Danube Aging study) (2014) (0)
FuelCal ® technology as new alternative method of disposal or use of animal by-products 1 Scientific Opinion of the Panel on Biological Hazards ( Question No EFSA-Q-2007-178 ) Adopted on 21 January 2009 (2009) (0)
Symposium neuropathologicum (2004) (0)
Targeting of prion-infected lymphoid cells to the central nervous system accelerates prion infection (2012) (0)
Neuropathology through the ages – personal reflections (2020) (0)
Deposits of disease-associated alpha-synuclein may be present in the dura mater in Lewy body disorders: implications for potential inadvertent transmission by surgery (2020) (0)
Chapter 28. Encephalitis (2008) (0)
ESETISMERTETÉS ASSOCIATION OF TEMPORAL LOBE INFLAMMATORY LEUKOENCEPHALOPATHY WITH TWO B CELL MALIGNANCIES (2014) (0)
The effect of Tubulin Polymerisation Promoting Protein (TPPP/p25) overexpression on the aggregation of alpha-synuclein (2009) (0)
Subject Index Vol. 30, 2008 (2008) (0)
Chapter 3 CENTRAL PATHOGENESIS OF PRION DISEASES (0)
Multifactorial White Matter Damage in the Acute Phase and Pre-Existing Conditions May Drive Cognitive Dysfunction after SARS-CoV-2 Infection: Neuropathology-Based Evidence (2023) (0)
Genetic TSE resistance in goats 1 Scientific Opinion of the Panel on Biological Hazards ( Question No EFSA-Q-2008-774 ) Adopted on 5 March 2009 (2009) (0)
UPDATE ON TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES (2006) (0)
Wide spectrum of neurodegenerative pathologies in a prospective longitudinal community-based study (2013) (0)
Franz Seitelberger (4 December 1916 to 2 November 2007) (2008) (0)
[Caudal regression, constrained position of the fetus in utero, maternal prediabetes]. (1977) (0)
Neuropathological relationships between Austria and Japan (2000) (0)
Creutzfeldt-Jakob disease in Austria. (1996) (0)
Book reviews – Announcements (2001) (0)
P2-213: Ultrastructural study of florid plaques in variant Creutzfeldt-Jakob disease: A comparison with kuru plaques in sporadic Creutzfeldt-Jakob and multicentric plaques of Gerstmann-Sträussler-Scheinker disease (2008) (0)
Virus production, cell proliferation and cell death in progressive multifocal leukoencephalopathy (1998) (0)
Peroxisomal alterations in Alzheimer's disease Jianqiu KouGabor G. KovacsRomana HoftbergerWillem KulikAlexander Brodde • Sonja Forss-PetterSelma HonigschnablAndreas GleissBritta BruggerRonald Wanders • Wilhelm JustHerbert BudkaSusanne JungwirthPeter FischerJohannes Berger (2011) (0)
Short Communication Disease-Associated Prion Protein in Vessel Walls (2002) (0)
Thalamic degeneration clinically presenting as CJD-More frequent than assumed? (2012) (0)
UPDATE ON THE PATHOGENESIS OF TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES (2005) (0)
Subacute and Chronic Viral Infections (2010) (0)
Edinburgh Research Explorer Rapidly progressive dementia with thalamic degeneration and peculiar cortical prion protein immunoreactivity, but absence of proteinase K resistant PrP (2013) (0)
SELECTIVE, SEVERE AND EARLY LOSS OF A SUBSET OF INHIBITORY NEURONS IN EXPERIMENTAL TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES (1998) (0)
Histotype-Dependent Oligodendroglial PrP Pathology in Sporadic CJD: A Frequent Feature of the M2C “Strain” (2021) (0)
ASSOCIATION OF TEMPORAL LOBE INFLAMMATORY LEUKOENCEPHALOPATHY WITH TWO B CELL MALIGNANCIES. (2014) (0)
Long-term clinical improvement of progressive multifocal leukoencephalopathy associated with prominent inflammatory response and follicular lymphoma (2011) (0)
Meeting report (2004) (0)
Cross-reactivity of human brain tumors with lymphoid- and hemapoietic-associated monoclonal antibodies (1985) (0)
UvA-DARE ( Digital Academic Repository ) Peroxisomal alterations in Alzheimer ' s disease (2011) (0)
II-C-02 Reduced expression of excitatory amino acid transporter-2 (EAAT-2) and activation of microglia in the cerebral cortex of AIDS patients(THE 45TH ANNUAL MEETING OF THE JAPAN SOCIETY OF HISTOCHEMISTRY AND CYTOCHEMISTRY) (2005) (0)
Comorbidity and prognosis in disproportionately enlarged subarachnoid space hydrocephalus (DESH-iNPH): Japanese and Austrian cohort studies (2017) (0)
Compassion for our colleagues and friends in Japan (2011) (0)
Tubulovesicular structures are consistently found in prion diseases including vCJD and FFI (2005) (0)
2010 International Congress of Neuropathology (2010) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Herbert Budka?

Herbert Budka is affiliated with the following schools:

Herbert Budka's Academic­Influence.com Rankings

Herbert Budka's Degrees

Why Is Herbert Budka Influential?

Herbert Budka's Published Works

Published Works

What Schools Are Affiliated With Herbert Budka?

Herbert Budka's AcademicInfluence.com Rankings